184 related articles for article (PubMed ID: 11157669)
1. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart.
Sanada S; Kitakaze M; Papst PJ; Hatanaka K; Asanuma H; Aki T; Shinozaki Y; Ogita H; Node K; Takashima S; Asakura M; Yamada J; Fukushima T; Ogai A; Kuzuya T; Mori H; Terada N; Yoshida K; Hori M
Circ Res; 2001 Feb; 88(2):175-80. PubMed ID: 11157669
[TBL] [Abstract][Full Text] [Related]
2. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
[TBL] [Abstract][Full Text] [Related]
3. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism.
Dana A; Skarli M; Papakrivopoulou J; Yellon DM
Circ Res; 2000 May; 86(9):989-97. PubMed ID: 10807872
[TBL] [Abstract][Full Text] [Related]
5. p38 MAPK activity is not increased early during sustained coronary artery occlusion in preconditioned versus control rabbit heart.
Gysembergh A; Simkhovich BZ; Kloner RA; Przyklenk K
J Mol Cell Cardiol; 2001 Apr; 33(4):681-90. PubMed ID: 11273721
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.
Tanno M; Gorog DA; Bellahcene M; Cao X; Quinlan RA; Marber MS
J Mol Cell Cardiol; 2003 Dec; 35(12):1523-7. PubMed ID: 14654378
[TBL] [Abstract][Full Text] [Related]
7. p38 MAP kinase is a mediator of ischemic preconditioning in pigs.
Schulz R; Belosjorow S; Gres P; Jansen J; Michel MC; Heusch G
Cardiovasc Res; 2002 Aug; 55(3):690-700. PubMed ID: 12160966
[TBL] [Abstract][Full Text] [Related]
8. Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways.
Heidbreder M; Naumann A; Tempel K; Dominiak P; Dendorfer A
Cardiovasc Res; 2008 Apr; 78(1):108-15. PubMed ID: 18096574
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
Barancik M; Htun P; Strohm C; Kilian S; Schaper W
J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
[TBL] [Abstract][Full Text] [Related]
10. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
11. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of mitogen-activated protein kinases in ischemic and anesthetic preconditioning.
da Silva R; Grampp T; Pasch T; Schaub MC; Zaugg M
Anesthesiology; 2004 Jan; 100(1):59-69. PubMed ID: 14695725
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase.
Sanada S; Kitakaze M; Papst PJ; Asanuma H; Node K; Takashima S; Asakura M; Ogita H; Liao Y; Sakata Y; Ogai A; Fukushima T; Yamada J; Shinozaki Y; Kuzuya T; Mori H; Terada N; Hori M
Circulation; 2001 Aug; 104(6):705-10. PubMed ID: 11489779
[TBL] [Abstract][Full Text] [Related]
14. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs.
Behrends M; Schulz R; Post H; Alexandrov A; Belosjorow S; Michel MC; Heusch G
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1111-9. PubMed ID: 10993774
[TBL] [Abstract][Full Text] [Related]
15. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-kappaB and iNOS.
Zhao TC; Taher MM; Valerie KC; Kukreja RC
Circ Res; 2001 Nov; 89(10):915-22. PubMed ID: 11701619
[TBL] [Abstract][Full Text] [Related]
16. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
17. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo.
Schulz R; Gres P; Skyschally A; Duschin A; Belosjorow S; Konietzka I; Heusch G
FASEB J; 2003 Jul; 17(10):1355-7. PubMed ID: 12759340
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of p38 MAPK during ischemia, but not reperfusion, effectively attenuates fatal arrhythmia in ischemia/reperfusion heart.
Surinkaew S; Kumphune S; Chattipakorn S; Chattipakorn N
J Cardiovasc Pharmacol; 2013 Feb; 61(2):133-41. PubMed ID: 23107875
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
Weinbrenner C; Liu GS; Cohen MV; Downey JM
J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
